United States · FDA National Drug Code directory
Venlafaxine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0477_2d034ebe-1e07-6fe0-e063-6394a90a368b
- Product NDC
- 80425-0477
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- venlafaxine hydrochloride
- Labeler
- Advanced Rx of Tennessee, LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20250130
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 37.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0477-1) · 80425-0477-1
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0477-2) · 80425-0477-2
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (80425-0477-3) · 80425-0477-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →